In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Intensity Therapeutics Inc (NASDAQ: INTS) closed at $0.46 in the last session, up 3.23% from day before closing price of $0.45. In other words, the price has increased by $3.23 from its previous closing price. On the day, 0.75 million shares were traded.
Ratios:
We take a closer look at INTS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.30.
Stock Price History:
Over the past 52 weeks, INTS has reached a high of $5.10, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -55.13%, while the 200-Day Moving Average is calculated to be -80.87%.
Shares Statistics:
A total of 15.26M shares are outstanding, with a floating share count of 10.02M. Insiders hold about 45.56% of the company’s shares, while institutions hold 14.16% stake in the company.
Earnings Estimates
The stock of Intensity Therapeutics Inc (INTS) is currently being evaluated by 1 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.7 and -$0.7 for the fiscal current year, implying an average EPS of -$0.7. EPS for the following year is -$0.47, with 2.0 analysts recommending between -$0.45 and -$0.5.
